XML 51 R23.htm IDEA: XBRL DOCUMENT v3.26.1
Related Party Transactions
 12 Months Ended
Dec. 31, 2025
Related Party Transactions [Abstract]  
Related Party Transactions Related Party Transactions
Through the Subscription Agreement and March 2024 PIPE Financing executed in conjunction with the Merger, the Company issued 3,343,330 shares to investors that had designated members on the Company's board of directors.
A member of the Company’s board of directors currently serves as a member of the board of directors of one of the Company’s vendors, and has served in that capacity since 2023. The Company has a Master Services Agreement with this vendor to provide manufacturing services, thus the Company considers the vendor to be a related party. For the years ended December 31, 2025 and 2024, total fees incurred for services performed by the vendor were $0.9 million and $0.5 million, respectively, and were charged to research and development expenses prior to FDA approval of VIZZ in July 2025. Subsequent to FDA approval of VIZZ, $0.5 million of the total fees incurred for the year ended December 31, 2025 were recorded within sales, general and administrative expenses. The Company had $0.1 million due to the vendor within accounts payable at both December 31, 2025 and December 31, 2024.